Tumour-suppressor genes (MLH1 and RUBCNL), protooncogene (AGR2), and genes reported to be linked with colon cancer (EPDR1, MLH1, AXIN2) were enriched in the signature. This evidence concerns the gene AXIN2 and neoplasm.